Psoriasis Treatment Market Poised for Strong Growth, Projected to Surpass $57 Billion by 2034
The global market for psoriasis treatments is on a significant growth trajectory, with new analysis projecting its value will exceed...
dermatology
Cutaneous Lupus Erythematosus Clinical Trial Pipeline Accelerates as Pharmaceutical Companies Race to Develop Transformative Treatments
The clinical development sector for cutaneous lupus erythematosus (CLE) is experiencing significant acceleration as more than ten pharmaceutical companies advance...
COSENTYX Breakthrough: FDA Approves First IL-17A Inhibitor for Pediatric Hidradenitis Suppurativa, Offering Hope for Adolescents
The U.S. Food and Drug Administration (FDA) has granted a significant approval to Novartis's COSENTYX® (secukinumab), authorizing its use for...
